Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrews

Showing results (41-50 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Disc sensitivity testing with ciprofloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|December 20, 1999
The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinoloneR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|April 5, 2000
In vitro susceptibility of Neisseria meningitidisJ M Andrews, R Wise
European Journal of Clinical Microbiology|October 1, 1983
A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaximeR Wise, J M Andrews
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Disk susceptibility testing for rufloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|April 1, 1994
The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogensJ M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of fludalanine combined with pentizidone compared with those of other agentsR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|March 4, 1998
The activity of grepafloxacin against respiratory pathogens in the UKR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|January 1, 1992
Susceptibility testing of cefpiromeJ M Andrews, R Wise
Pageof 37

Showing results (41-50 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Disc sensitivity testing with ciprofloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|December 20, 1999
The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinoloneR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|April 5, 2000
In vitro susceptibility of Neisseria meningitidisJ M Andrews, R Wise
European Journal of Clinical Microbiology|October 1, 1983
A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaximeR Wise, J M Andrews
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Disk susceptibility testing for rufloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|April 1, 1994
The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogensJ M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of fludalanine combined with pentizidone compared with those of other agentsR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|March 4, 1998
The activity of grepafloxacin against respiratory pathogens in the UKR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|January 1, 1992
Susceptibility testing of cefpiromeJ M Andrews, R Wise
Pageof 37